Skip to main content
Clinical Trials/NL-OMON45518
NL-OMON45518
Recruiting
Not Applicable

An observational neuroimaging and neurophysiological study investigating the visual pathway in Huntington*s disease. - Visual pathway in HD.

eids Universitair Medisch Centrum0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
hereditary neurodegenerative movement disorder
Sponsor
eids Universitair Medisch Centrum
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* Between 18 and 65 years of age at time of visit
  • \* Ability to undergo MRI scanning
  • \* Written informed consent must be obtained from the participant;If the participant is a manifest HD gene carrier:
  • \* Gene positive tested with CAG repeat length of \* 36 in the HTT gene
  • \* UHDRS\-TMS \> 5;If the participant is a premanifest HD gene carrier:
  • \* Gene positive tested with CAG repeat length of \* 36 in the HTT gene
  • \* UHDRS\-TMS \* 5;If the participant is a control subject:
  • \* Gene negative tested for HD or without family history of HD
  • \* No other known cognitive, neurological or psychiatric disorders

Exclusion Criteria

  • \* Impaired primary visual ability (\<0\.5\) or ophthalmic disorders
  • (including amblyopia or color vision deficiency)
  • \* Additional major co\-morbidities not related to HD
  • (e.g. cardiovascular diseases, hypertension, diabetes mellitus, and/or other neurological disorders)
  • \* History of severe head injury
  • \* Contra\-indication for MRI (metallic implants/devices, claustrophobia)
  • \* Participation in intervention trials
  • \* Pregnancy
  • \* Inability to understand the information about the protocol

Outcomes

Primary Outcomes

Not specified

Similar Trials